Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
Ultrasound is routinely used to screen for HCC. However, its utility is limited by numerous factors, including patient body habitus, operator experience and certain liver conditions, all of which contribute to decreases in sensitivity.
In conjunction with prevention efforts, the introduction of screening examinations has resulted in a reduction of nearly 6 million cancer-related deaths since 1975.
Breast density is most often discussed within the context of cancer risk, but new research suggests that it also could be used as a marker of cardiometabolic health.
The obesity epidemic in the United States threatens accuracy in diagnostic medical imaging studies - according to a 15-year retrospective study of all radiologic exams performed at the Massachusetts General Hospital (MGH) in Boston.
Boosting its presence in Europe's healthcare IT market, Agfa Healthcare inked a $338 million agreement to acquire healthcare information systems and electronic health records (EHR) developer GWI of Bonn, Germany.
Image management software developer Cedara Software Corp. and DR provider ANEXA Corp., a subsidiary of Analogic Corp., have paired to deliver integrated digital imaging systems to the radiology community.
Emageon Inc. this week filed a registration statement with the Securities and Exchange Commission (SEC) for a proposed initial public offering of its common stock.
Siemens Medical Solutions is introducing a new mobile C-arm with intra-operative three dimensional (3D) imaging capabilities to generate 3D images directly in the operating room (OR) at next week's Radiological Society of North America meeting, Nov. 28 -
Mercury Computer Systems Inc. and NVIDIA Corp. have entered a joint agreement to develop and deliver image processing technologies for the life sciences and geosciences markets.
Speech recognition software provider ScanSoft Inc. and EMR developer SynaMed will deliver an electronic medical record (EMR) software package with integrated speech recognition.
Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care.
